Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
01 11Pharmathen SA
02 4Amdipharm Mercury Company Limited
03 4Biological E
04 9CHEMO
05 8Centocor
06 8Janssen-Cilag
07 15Johnson & Johnson Innovative Medicine
08 6LUYE INNOMIND PHARMA
09 2ORIFARM GROUP AS
10 1Pharmascience Inc.
11 5Teva Pharmaceutical Industries
12 5Tolmar
13 1Viatris
01 9Aqueous Suspension
02 14Depot solution for injection, suspension
03 11Long Acting Injectable
04 4PFS
05 4Pre Filled Syringe
06 8SUSPENSION (EXTENDED-RELEASE)
07 1SUSPENSION, EXTENDED RELEASE;INJECTABLE
08 27SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
09 1SUSPENSION;EXTENDED RELEASE
01 5EU Approved
02 4Originator
03 8Prescription
04 22RX
05 6USA
06 34Blank
01 6ERZOFRI
02 2INVEGA HAFYERA
03 9INVEGA SUSTENNA
04 8INVEGA TRINZA
05 12PALIPERIDONE PALMITATE
06 4Palmeux
07 4Trevicta
08 1Trevicta 175MG
09 1Trevicta 263 MG
10 1Trevicta 350 MG
11 1Trevicta 525 MG
12 6Xeplion
13 24Blank
01 8Canada
02 11Greece
03 4India
04 14Norway
05 4South Africa
06 9Spain
07 29USA
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Long Acting Injectable
Dosage Strength : 25MG/SYRINGE
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Long Acting Injectable
Dosage Strength : 50MG/SYRINGE
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Long Acting Injectable
Dosage Strength : 75MG/SYRINGE
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Long Acting Injectable
Dosage Strength : 100MG/SYRINGE
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Long Acting Injectable
Dosage Strength : 150MG/SYRINGE
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : USA
Registration Country : Greece
Brand Name :
Dosage Form : Long Acting Injectable
Dosage Strength : 175MG/SYRINGE
Packaging :
Approval Date :
Application Number :
Regulatory Info : USA
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : USA
Registration Country : Greece
Brand Name :
Dosage Form : Long Acting Injectable
Dosage Strength : 263MG/SYRINGE
Packaging :
Approval Date :
Application Number :
Regulatory Info : USA
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : USA
Registration Country : Greece
Brand Name :
Dosage Form : Long Acting Injectable
Dosage Strength : 350MG/SYRINGE
Packaging :
Approval Date :
Application Number :
Regulatory Info : USA
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : USA
Registration Country : Greece
Brand Name :
Dosage Form : Long Acting Injectable
Dosage Strength : 525MG/SYRINGE
Packaging :
Approval Date :
Application Number :
Regulatory Info : USA
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : USA
Registration Country : Greece
Brand Name :
Dosage Form : Long Acting Injectable
Dosage Strength : 700MG/SYRINGE
Packaging :
Approval Date :
Application Number :
Regulatory Info : USA
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : USA
Registration Country : Greece
Brand Name :
Dosage Form : Long Acting Injectable
Dosage Strength : 1000MG/SYRINGE
Packaging :
Approval Date :
Application Number :
Regulatory Info : USA
Registration Country : Greece
Regulatory Info : RX
Registration Country : USA
Brand Name : INVEGA SUSTENNA
Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
Dosage Strength : 39MG/0.25ML (39MG/0.25ML)
Packaging :
Approval Date : 2009-07-31
Application Number : 22264
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : INVEGA SUSTENNA
Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
Dosage Strength : 78MG/0.5ML (78MG/0.5ML)
Packaging :
Approval Date : 2009-07-31
Application Number : 22264
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : INVEGA SUSTENNA
Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
Dosage Strength : 117MG/0.75ML (117MG/0.75ML)
Packaging :
Approval Date : 2009-07-31
Application Number : 22264
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : INVEGA SUSTENNA
Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
Dosage Strength : 156MG/ML (156MG/ML)
Packaging :
Approval Date : 2009-07-31
Application Number : 22264
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : INVEGA SUSTENNA
Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
Dosage Strength : 234MG/1.5ML (156MG/ML)
Packaging :
Approval Date : 2009-07-31
Application Number : 22264
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : INVEGA TRINZA
Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
Dosage Strength : 273MG/0.875ML (273MG/0.875ML)
Packaging :
Approval Date : 2015-05-18
Application Number : 207946
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : INVEGA TRINZA
Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
Dosage Strength : 410MG/1.315ML (311.79MG/ML)
Packaging :
Approval Date : 2015-05-18
Application Number : 207946
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : INVEGA TRINZA
Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
Dosage Strength : 546MG/1.75ML (312MG/ML)
Packaging :
Approval Date : 2015-05-18
Application Number : 207946
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : INVEGA TRINZA
Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
Dosage Strength : 819MG/2.625ML (312MG/ML)
Packaging :
Approval Date : 2015-05-18
Application Number : 207946
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : INVEGA HAFYERA
Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
Dosage Strength : 1.092GM/3.5ML (312MG/ML)
Packaging :
Approval Date : 2021-08-30
Application Number : 207946
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : INVEGA HAFYERA
Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
Dosage Strength : 1.560GM/5ML (312MG/ML)
Packaging :
Approval Date : 2021-08-30
Application Number : 207946
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALIPERIDONE PALMITATE
Dosage Form : SUSPENSION;EXTENDED RELEASE
Dosage Strength :
Packaging :
Approval Date :
Application Number : 210397
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALIPERIDONE PALMITATE
Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
Dosage Strength : 39MG/0.25ML (39MG/0.25ML)
Packaging :
Approval Date : 2021-07-06
Application Number : 211149
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALIPERIDONE PALMITATE
Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
Dosage Strength : 78MG/0.5ML (78MG/0.5ML)
Packaging :
Approval Date : 2021-07-06
Application Number : 211149
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALIPERIDONE PALMITATE
Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
Dosage Strength : 117MG/0.75ML (117MG/0.75ML)
Packaging :
Approval Date : 2021-07-06
Application Number : 211149
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALIPERIDONE PALMITATE
Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
Dosage Strength : 156MG/ML (156MG/ML)
Packaging :
Approval Date : 2021-07-06
Application Number : 211149
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALIPERIDONE PALMITATE
Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
Dosage Strength : 234MG/1.5ML (156MG/ML)
Packaging :
Approval Date : 2021-07-06
Application Number : 211149
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALIPERIDONE PALMITATE
Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
Dosage Strength : 39MG/0.25ML
Packaging :
Approval Date :
Application Number : 211995
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALIPERIDONE PALMITATE
Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
Dosage Strength : 78MG/0.5ML
Packaging :
Approval Date :
Application Number : 211995
Regulatory Info :
Registration Country : USA
LOOKING FOR A SUPPLIER?
